Organon & Co. (NYSE:OGN) Is a Favorite Amongst Institutional Investors Who Own 80%

Key Insights Significantly high institutional ownership implies Organon's stock price is sensitive to their trading actions The top 15 shareholders own 50% of the company Ownership research along

Simply Wall StJun 9 21:39

Express News | NYSE Order Imbalance 104610.0 Shares on Buy Side

BreakingsJun 1 03:50

Express News | NYSE Order Imbalance 56041.0 Shares on Buy Side

BreakingsMay 31 03:50

Express News | NYSE Order Imbalance 107268.0 Shares on Buy Side

BreakingsMay 29 03:50

Express News | European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (Denosumab) Biosimilar Candidate Hlx14

BreakingsMay 24 18:00

Organon & Co Spearheads Kahn Brothers' Strategic Portfolio Enhancements in Q1 2024

Yahoo FinanceMay 16 04:01